Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancer and thromboembolism].

N Hara1, H Kotho, K Kuwano

  • 1Research Institute for Diseases of the Chest, Faculty of Medicine, Kyushu University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 3, 1999
PubMed
Summary

Thromboembolism, a frequent complication in cancer patients, arises from cancer-induced hemostatic changes. Early detection and treatment, including low molecular heparin, are crucial for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory syncytial virus pneumonia in an immunocompetent adult: an important differential diagnosis of COVID-19.

QJM : monthly journal of the Association of Physicians·2022
Same author

EprS, an autotransporter serine protease, plays an important role in various pathogenic phenotypes of Pseudomonas aeruginosa.

Microbiology (Reading, England)·2015
Same author

Use of FM1-43, a membrane-specific fluorescent dye, to estimate plasma membrane integrity in the cryopreservation of green algae.

Cryo letters·2014
Same author

Strong coupling superconductivity at 8.4 K in an antiperovskite phosphide SrPt3P.

Physical review letters·2012
Same author

Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium.

International archives of allergy and immunology·2012
Same author

Apoptosis signaling pathways in lung diseases.

Medicinal chemistry (Shariqah (United Arab Emirates))·2006

Area of Science:

  • Oncology
  • Hematology
  • Pathophysiology

Context:

  • Thromboembolism is a prevalent complication in patients diagnosed with malignant diseases.
  • Cancer-associated thromboembolism (CAT) significantly impacts patient morbidity and mortality.
  • Understanding the intricate mechanisms of CAT is vital for effective clinical management.

Purpose:

  • To elucidate the pathogenesis of thromboembolism in cancer patients.
  • To highlight the role of cancer cells and associated inflammatory responses in hemostatic alterations.
  • To discuss current therapeutic strategies for managing cancer-related thromboembolic events.

Summary:

  • Cancer induces hemostatic alterations, including endothelial injury, coagulation activation, and impaired anticoagulation, leading to thromboembolism.
  • These thromboembolic events can occur even in patients with occult or early-stage cancer.
  • Recent advancements include the use of low molecular weight heparin alongside prompt cancer treatment.

Impact:

  • Improved understanding of CAT pathogenesis can lead to targeted preventive strategies.
  • Early recognition and intervention for thromboembolism in cancer patients can improve outcomes.
  • Integration of anticoagulant therapy with cancer treatment offers a more comprehensive management approach.

Related Experiment Videos